Home/Filings/4/0001493152-24-048951
4//SEC Filing

Mohan Pankaj 4

Accession 0001493152-24-048951

CIK 0001106838other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 9:55 PM ET

Size

7.1 KB

Accession

0001493152-24-048951

Insider Transaction Report

Form 4
Period: 2023-12-11
Mohan Pankaj
DirectorChairman, President and CEO
Transactions
  • Award

    Common Stock

    2023-12-11+7,55414,987 total
Holdings
  • Common Stock

    (indirect: By Children)
    3
  • Common Stock

    (indirect: By Mohan Family Office)
    377
Footnotes (4)
  • [F1]On December 11, 2023, the Reporting Person was granted 7,554 restricted stock awards, which will be settled in shares of common stock, par value $0.0001. The shares in connection with the restricted stock award become fully vested on January 1, 2025.
  • [F2]Includes unvested restricted stock awards.
  • [F3]All amounts reflect the Issuer's 1:22 reverse stock split effective as of September 30, 2024.
  • [F4]Reporting Person jointly exercises dispositive and voting power over the securities owned by the Mohan Family Office.

Documents

1 file

Issuer

Sonnet BioTherapeutics Holdings, Inc.

CIK 0001106838

Entity typeother

Related Parties

1
  • filerCIK 0001664386

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 9:55 PM ET
Size
7.1 KB